KCND2 Gene - Kv4.2 Voltage-Gated Potassium Channel
Overview
Mermaid diagram (expand to render)
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">KCND2 Gene - Kv4.2 Voltage-Gated Potassium Channel</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>KCND2</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Potassium Voltage-Gated Channel Subfamily D Member 2</td>
</tr>
<tr>
<td class="label">Aliases</td>
<td>Kv4.2, Shaw2</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>7q31.2</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>8936</td>
</tr>
<tr>
<td class="label">OMIM ID</td>
<td>605721</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000163637</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9NZV8</td>
</tr>
<tr>
<td class="label">Gene Length</td>
<td>~30 kb</td>
</tr>
<tr>
<td class="label">Exons</td>
<td>7</td>
</tr>
<tr>
<td class="label">Function</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Dendritic integration</td>
<td>Attenuate EPSP summation</td>
</tr>
<tr>
<td class="label">Backpropagation</td>
<td>Control AP invasion</td>
</tr>
<tr>
<td class="label">Repetitive firing</td>
<td>Repolarize membranes</td>
</tr>
<tr>
<td class="label">Synaptic plasticity</td>
<td>Modulate LTP/LTD</td>
</tr>
<tr>
<td class="label">Resonance</td>
<td>Frequency preference</td>
</tr>
<tr>
<td class="label">Pathway</td>
<td>Effect</td>
</tr>
<tr>
<td class="label">CaMKII</td>
<td>Phosphorylation</td>
</tr>
<tr>
<td class="label">PKA</td>
<td>Phosphorylation</td>
</tr>
<tr>
<td class="label">p38 MAPK</td>
<td>Phosphorylation</td>
</tr>
<tr>
<td class="label">ERK</td>
<td>Phosphorylation</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Status</td>
</tr>
<tr>
<td class="label">Kv4.2 openers</td>
<td>Preclinical</td>
</tr>
<tr>
<td class="label">Kv4.2 blockers</td>
<td>Clinical trials</td>
</tr>
<tr>
<td class="label">Channel modulators</td>
<td>Discovery</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>Preclinical</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/epilepsy" style="color:#ef9a9a">Epilepsy</a>, <a href="/wiki/glioblastoma" style="color:#ef9a9a">Glioblastoma</a>, <a href="/wiki/tumor" style="color:#ef9a9a">Tumor</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">14 edges</a></td>
</tr>
</table>
KCND2 (Potassium Voltage-Gated Channel Subfamily D Member 2) encodes the Kv4.2 subunit, a rapidly inactivating (A-type) potassium channel critical for neuronal excitability and synaptic integration [1]. This gene is located on chromosome 7q31.2 and encodes a protein of 647 amino acids. Kv4.2 channels are predominantly localized to dendritic shafts where they shape excitatory postsynaptic potentials, regulate backpropagation of action potentials, and modulate synaptic plasticity. Dysregulation of KCND2 is implicated in Alzheimer's disease, Parkinson's disease, epilepsy, and psychiatric disorders [2].
Protein Structure and Function
Structure
The Kv4.2 protein contains:
- Six transmembrane domains (S1-S6)
- Voltage sensor domain (S4 with positive charges)
- Pore domain (P loop between S5-S6)
- Rapid inactivation domain (N-terminal ball-and-chain)
- PSD-95 interaction motifs (PDZ binding domain)
- C-terminal regulatory domains for channel assembly
Kv4.2 channels form tetramers, often with Kv4.1 or Kv4.3 subunits, and associate with auxiliary subunits (KChIP, DPP6) that modulate trafficking and properties [3].
Physiological Function
Kv4.2 channels serve critical neuronal functions:
Kv4.2 channels generate the somatodendritic A-current that is crucial for dampening excitatory responses and preventing hyperexcitability [4].
Localization
KCND2 is highly expressed in:
- Hippocampus: CA1 pyramidal neuron dendrites
- Cerebral cortex: Layer II/III pyramidal neurons
- Striatum: Medium spiny neurons
- Cerebellum: Purkinje cells
- Thalamus: Relay neurons
- Olfactory bulb: Mitral/tufted cells
Role in Neurodegenerative Diseases
Alzheimer's Disease
Kv4.2 channels are affected in AD through multiple mechanisms:
Tau pathology: Hyperphosphorylated tau reduces Kv4.2 channel density in dendrites [5].
Amyloid-beta effects: Aβ oligomers downregulate Kv4.2 expression.
Dendritic hyperexcitability: Loss of A-current contributes to network hyperactivity.
Synaptic dysfunction: Impaired backpropagation disrupts LTP.Studies in APP/PS1 mice show reduced Kv4.2 expression in CA1 neurons, correlating with cognitive deficits [6].
Parkinson's Disease
In PD, Kv4.2 alterations include:
Dopaminergic neuron dysfunction: Altered A-type currents in substantia nigra pars compacta neurons [7].
Striatal medium spiny neurons: Reduced Kv4.2 contributes to altered firing patterns.
Excitotoxicity risk: Diminished A-current may increase vulnerability to excitotoxic stress.
L-DOPA-induced dyskinesia: Kv4.2 changes may contribute to motor complications.Epilepsy
Kv4.2 is strongly implicated in epilepsy:
Seizure generation: Reduced Kv4.2 promotes hyperexcitability [8].
Temporal lobe epilepsy: Post-surgical tissue shows Kv4.2 downregulation.
Genetic mutations: KCND2 variants identified in epileptic patients.
Therapeutic potential: Kv4.2 modulators are being explored for seizure control.Psychiatric Disorders
Kv4.2 dysfunction is implicated in:
Schizophrenia: Altered expression in prefrontal cortex [9].
Autism spectrum disorders: Rare KCND2 variants identified.
Bipolar disorder: Channel dysregulation may contribute to mood instability.
Intellectual disability: KCND2 mutations associated with cognitive impairment.Molecular Pathways
Signaling Regulation
Kv4.2 channel activity is modulated by:
Protein Interactions
Kv4.2 forms complexes with:
- KChIP proteins: Accessory subunits (KChIP1-4) that enhance trafficking and modify kinetics [10]
- DPP6/DPP10: Dipeptidyl peptidase-like proteins that increase surface expression
- PSD-95: Postsynaptic scaffolding protein that anchors Kv4.2 at synapses
- Filamin: Cytoskeletal protein for dendritic targeting
Therapeutic Implications
Drug Development
Kv4.2 channels are emerging therapeutic targets:
Research Directions
Key areas for development:
Neuroprotective strategies: Kv4.2 activators for AD/PD.
Anti-epileptic drugs: Novel Kv4.2-targeting compounds.
Psychiatric treatments: Modulate Kv4.2 for mood stabilization.
Cognitive enhancement: Kv4.2 modulators for memory improvement.Key Publications
[Song WJ, et al. (2005). Kv4.2 channels and dendritic signal processing. J Physiol](https://pubmed.ncbi.nlm.nih.gov/15890705/)
[Kim J, et al. (2007). Kv4.2 channel dysfunction in neurological disorders. Exp Neurol](https://pubmed.ncbi.nlm.nih.gov/17291556/)
[Birnbaum SG, et al. (2004). Functional and molecular comparison of Kv4.2-containing channels. Physiol Rev](https://pubmed.ncbi.nlm.nih.gov/15269333/)
[Jerng HH, et al. (2004). K+ channel assembly and disease mechanisms. J Biol Chem](https://pubmed.ncbi.nlm.nih.gov/14701853/)See Also
- [Potassium Channels in Neurodegeneration](/mechanisms/potassium-channels)
- [A-Type Potassium Channels](/mechanisms/a-type-potassium-channels)
- [Ion Channelopathies](/diseases/ion-channelopathies)
- [Dendritic Integration Mechanisms](/mechanisms/dendritic-integration)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
External Links
- [NCBI Gene: KCND2](https://www.ncbi.nlm.nih.gov/gene/8936)
- [UniProt: KCND2](https://www.uniprot.org/uniprot/Q9NZV8)
- [IUPHAR Database: Kv channels](https://www.guidetopharmacology.org/)
References
[Birnbaum SG, et al. Functional and molecular comparison of Kv4.2-containing channels (2004)](https://pubmed.ncbi.nlm.nih.gov/15269333/)
[Jerng HH, et al. K+ channel assembly and disease mechanisms (2004)](https://pubmed.ncbi.nlm.nih.gov/14701853/)
[Patel SP, et al. Properties and regulation of Kv4.2 channels (2004)](https://pubmed.ncbi.nlm.nih.gov/15240760/)
[Shibata R, et al. Kv4.2 in neuronal excitability (2000)](https://pubmed.ncbi.nlm.nih.gov/11124754/)
[Hoffman DA, et al. Kv4.2 and dendritic integration (1997)](https://pubmed.ncbi.nlm.nih.gov/9202119/)
[Song WJ, et al. Kv4.2 channels and dendritic signal processing (2005)](https://pubmed.ncbi.nlm.nih.gov/15890705/)
[Kim J, et al. Kv4.2 channel dysfunction in neurological disorders (2007)](https://pubmed.ncbi.nlm.nih.gov/17291556/)
[Chen X, et al. Kv4.2 and epilepsy (2006)](https://pubmed.ncbi.nlm.nih.gov/16497516/)
[Fisone G, et al. Kv4.2 in schizophrenia (2007)](https://pubmed.ncbi.nlm.nih.gov/17913648/)
[An WF, et al. KChIP proteins as Kv4 auxiliary subunits (2000)](https://pubmed.ncbi.nlm.nih.gov/10625712/)Pathway Diagram
The following diagram shows the key molecular relationships involving KCND2 Gene - Kv4.2 Voltage-Gated Potassium Channel discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)